Amicus Therapeutics, Inc.
FOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $191 | $159 | $182 | $214 |
| Short-Term Investments | $73 | $72 | $69 | $36 |
| Receivables | $114 | $106 | $88 | $101 |
| Inventory | $178 | $155 | $132 | $119 |
| Other Curr. Assets | $38 | $46 | $39 | $35 |
| Total Curr. Assets | $594 | $538 | $511 | $505 |
| Property Plant & Equip (Net) | $49 | $51 | $51 | $52 |
| Goodwill | $198 | $198 | $198 | $198 |
| Intangibles | $15 | $16 | $16 | $17 |
| Long-Term Investments | $0 | $3 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $13 | $10 | $14 | $14 |
| Total NC Assets | $275 | $277 | $279 | $280 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $869 | $815 | $790 | $785 |
| Liabilities | – | – | – | – |
| Payables | $19 | $14 | $14 | $13 |
| Short-Term Debt | $9 | $9 | $9 | $8 |
| Tax Payable | $0 | $0 | $0 | $18 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $171 | $145 | $130 | $109 |
| Total Curr. Liab. | $199 | $168 | $153 | $149 |
| LT Debt | $434 | $435 | $435 | $435 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $9 | $8 | $7 |
| Total NC Liab. | $439 | $443 | $443 | $442 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $51 | $52 | $53 | $54 |
| Total Liabilities | $638 | $611 | $596 | $591 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$2,769 | -$2,786 | -$2,762 | -$2,740 |
| AOCI | $23 | $31 | $13 | $5 |
| Other Equity | $2,974 | $2,957 | $2,940 | $2,926 |
| Total Equity | $230 | $204 | $194 | $194 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $869 | $815 | $790 | $785 |
| Net Debt | $252 | $285 | $262 | $230 |